Neuropsychopharmacology
- IN MEMORIAM: Floyd E. Bloom, M.D1 year ago
- Central Executive Network drives delta-9-tetrahydrocannabinol (THC)-induced nonlinear changes in large-scale functional connectivity in adolescent nonhuman primates1 year ago
- A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse1 year ago
- The crosstalk between CREB and PER2 mediates the transition between mania- and depression-like behavior1 year ago
- Connectome-based predictive modeling of early and chronic psychosis symptoms1 year ago
- The prelimbic prefrontal cortex mediates the development of lasting social avoidance as a consequence of social threat conditioning1 year ago
- A projection from the medial prefrontal cortex to the lateral septum modulates coping behavior on the shock-probe test1 year ago
Journal of Psychopharmacology
- Wistar Kyoto rats exhibit decreased serotonin neuronal firing and increased norepinephrine burst activity but dampened hippocampal α2-adrenoceptor sensitivity3 years ago
- Causes, clinical characteristics, and outcomes of high lithium levels and intoxications: Retrospective analysis of patient records3 years ago
- Kynurenine pathway and suicidal ideation in treatment-resistant depression3 years ago
- Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview3 years ago
- The potential for medicinal cannabis to help manage challenging behaviour in people with intellectual disability: A perspective review3 years ago
- The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies3 years ago
- Psychological and physiological effects of extended DMT3 years ago
European Neuropsychopharmacology
- The complex scenario behind the term antipsychotic drug2 years ago
- Can antipsychotics prevent transition to psychosis in high-risk population?2 years ago
- From gut to brain: A network model of intestinal permeability, inflammation, and psychotic symptoms in schizophrenia.2 years ago
- Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indices2 years ago
- Investigation of TRPV1 gene expression in bipolar disorder and its association with CB1 and MOR gene expression2 years ago
- The never-ending problem: Sample size matters2 years ago
- Obsessiveācompulsive symptoms and 15q11.2q13.1 duplication syndrome2 years ago